Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.
Metagen Therapeutics has raised $7.6M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
Metagen Therapeutics is headquartered in Tsuruoka, Japan.
Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.
Metagen Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Metagen Therapeutics — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/metagen-therapeutics. Accessed September 2, 2026.
VCBacked. (2026). Metagen Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/metagen-therapeutics
{{cite web |title=Metagen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/metagen-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated